Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-027411
Filing Date
2024-11-21
Accepted
2024-11-21 16:30:07
Documents
1
Period of Report
2024-11-19

Document Format Files

Seq Description Document Type Size
1 form4-11212024_041104.html 4  
1 form4-11212024_041104.xml 4 8603
  Complete submission text file 0001415889-24-027411.txt   10125
Mailing Address 12481 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO CA 92130
Business Address
Lowenthal Richard E (Reporting) CIK: 0001378550 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39756 | Film No.: 241484857

Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Issuer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)